The Genome-Wide Expression Profile of Nelumbinis semen on Lipopolysaccharide-Stimulated BV-2 Microglial Cells
BIOLOGICAL & PHARMACEUTICAL BULLETIN
Authors: Sohn, Sung-Hwa; Chung, Hwan-Suck; Ko, Eunjung; Jeong, Hyuk-joon; Kim, Sung-Hoon; Jeong, Jin-Hyun; Kim, Yangseok; Shin, Minkyu; Hong, Moochang; Bae, Hyunsu
Abstract
This study was conducted to evaluate the protective mechanisms of Nelumbinis semen (NS) on lipopolysaccharide (LPS)-induced activation of BV-2 microglial cells. The anti-inflammatory effects of NS were determined by analyzing nitric oxide production and proinflammatory cytokines using enzyme-linked immunosorbent assay. The mechanism was evaluated in BV-2 cells with or without NS treated with LPS for various lengths of time using oligonucleotide microarray and real time reverse transcription-polymerase chain reaction. The oligonucleotide microarray analysis revealed that mitogen activated protein kinase (MAPK) signaling pathway-related genes such as Fgfr3, Fgf12, Rasa12, Nfkb2, Map2k5, Mapk1, Map3k7, and NFatc2 were down-regulated in LPS activated BV-2 cells by pretreatment with NS. In addition, significant decreases in Nos1ap gene expression were observed with NS pretreatment. Cluster linked pathway analysis using the Kyoto Encyclopedia of Genes and Genomes database revealed that the effects of NS were closely associated with the regulation of mitochondria functions. These results suggested that NS can affect the MAPK signaling pathway and mitochondrial functions in BV-2 cells activated with LPS.
NOTCH and NF-kappa B interplay in chronic lymphocytic leukemia is independent of genetic lesion
INTERNATIONAL JOURNAL OF HEMATOLOGY
Authors: Baldoni, Stefano; Sportoletti, Paolo; Del Papa, Beatrice; Aureli, Patrizia; Dorillo, Erica; Rosati, Emanuela; Ciurnelli, Raffaella; Marconi, Pierfrancesco; Falzetti, Franca; Di Ianni, Mauro
Abstract
The NOTCH and nuclear factor kappa B (NF-kappa B) pathways are both constitutively activated in Chronic Lymphocytic Leukemia (CLL). We first described the NOTCH1 PEST domain mutation in a CLL subgroup, but the activation of the NOTCH pathway in NOTCH1-unmutated cases remains unexplained. Here, we investigated whether genetic lesions in the NF-kappa B/NOTCH loop might support the NOTCH activation status by sequencing negative (TNFAIP3/A20) and positive (TRAF2, TRAF5, TNFRSF11A/RANK, MAP3K7/TAK1, and CARD11) regulators of NF-kappa B together with NF-kappa B targets on the NOTCH pathway, the NOTCH ligands Jagged1 and Jagged2, in CLL patients. The sequence analysis revealed four missense mutations for A20, TRAF2, TRAF5 and RANK1 genes, all causing a change in amino acid group from polar to non-polar, but functional domains were not involved. Specific predictive software analyses confirmed that the amino acid changes have a low-functional impact on the protein. Our results show that in CLL, NF-kappa B regulators and Jagged are both unmutated, suggesting that the Jagged-mediated interplay between NF-kappa B and NOTCH is independent of genetic lesions.